Corrigendum to “Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging” [Radiother Oncol 113(3) (2014) 324–30](S0167814014003922)(10.1016/j.radonc.2014.09.005));Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging

Radiotherapy and Oncology

Volumn 113, Issue 3, 2014, Pages 324-330

  Rios Velazquez, Emmanuel ^a,b   Hoebers, Frank ^a   Aerts, Hugo J W L ^b   Rietbergen, Michelle M ^c   Brakenhoff, Ruud H ^c   Leemans, René C ^c   Speel, Ernst Jan ^c   Straetmans, Jos ^c   Kremer, Bernd ^c   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Decision support systems; Human papillomavirus; Oropharyngeal cancer; Outcome prediction; Predictive nomogram

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMORBIDITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; SMOKING; TREATMENT OUTCOME; WART VIRUS; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; HEAD AND NECK NEOPLASMS; ISOLATION AND PURIFICATION; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; VALIDATION STUDY; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 84915790929     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2017.06.017     Document Type: Erratum

References (27)

1. D.J. Adelstein, and C.P. Rodriguez Human papillomavirus: changing paradigms in oropharyngeal cancer Curr Oncol Rep 12 2010 115 120
2. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
3. S. Marur, G. D'Souza, W.H. Westra, and A.A. Forastiere HPV-associated head and neck cancer: a virus-related cancer epidemic Lancet Oncol 11 2010 781 789
4. K.K. Ang, and E.M. Sturgis Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma Semin Radiat Oncol 22 2012 128 142
5. M.L. Gillison, Q. Zhang, R. Jordan, W. Xiao, W.H. Westra, and A. Trotti Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol 30 2012 2102 2111
6. A.P. Abernethy, L.M. Etheredge, P.A. Ganz, P. Wallace, R.R. German, and C. Neti Rapid-learning system for cancer care J Clin Oncol 28 2010 4268 4274
7. P. Lambin, E. Roelofs, B. Reymen, E.R. Velazquez, J. Buijsen, and C.M. Zegers Rapid Learning health care in oncology - an approach towards decision support systems enabling customised radiotherapy Radiother Oncol 109 2013 159 164
8. M.M. Rietbergen, R.H. Brakenhoff, E. Bloemena, B.I. Witte, P.J. Snijders, and D.A. Heideman Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials Ann Oncol 24 2013 2740 2745
9. H.C. Hafkamp, J.J. Manni, A. Haesevoets, A.C. Voogd, M. Schepers, and F.J. Bot Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas Int J Cancer 122 2008 2656 2664
10. D. Kallogjeri, J.F. Piccirillo, E.L. Spitznagel Jr.; and E.W. Steyerberg Comparison of scoring methods for ACE-27: simpler is better J Geriatr Oncol 3 2012 238 245
11. B. O'Sullivan, S.H. Huang, L.L. Siu, J. Waldron, H. Zhao, and B. Perez-Ordonez Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis J Clin Oncol 31 2013 543 550
12. T.P. Morris, I.R. White, and P. Royston Tuning multiple imputation by predictive mean matching and local residual draws BMC Med Res Methodol 14 2014 75
13. A. Iasonos, D. Schrag, G.V. Raj, and K.S. Panageas How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 2008 1364 1370
14. R. Granata, R. Miceli, E. Orlandi, F. Perrone, B. Cortelazzi, and M. Franceschini Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study Ann Oncol 23 2012 1832 1837
15. D. Rischin, R.J. Young, R. Fisher, S.B. Fox, Q.T. Le, and L.J. Peters Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial J Clin Oncol 28 2010 4142 4148
16. J.M. Straetmans, N. Olthof, J.J. Mooren, J. de Jong, E.J. Speel, and B. Kremer Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas Laryngoscope 119 2009 1951 1957
17. B.M. Lin, H. Wang, G. D'Souza, Z. Zhang, C. Fakhry, and A.W. Joseph Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma Cancer 119 2013 3462 3471
18. A.S. Garden, M.S. Kies, W.H. Morrison, R.S. Weber, S.J. Frank, and B.S. Glisson Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century Radiat Oncol 8 2013 21
19. P. Lambin, R.G. van Stiphout, M.H. Starmans, E. Rios-Velazquez, G. Nalbantov, and H.J. Aerts Predicting outcomes in radiation oncology - multifactorial decision support systems Nat Rev Clin Oncol 10 2013 27 40
20. E. Roelofs, L. Persoon, S. Nijsten, W. Wiessler, A. Dekker, and P. Lambin Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial Radiother Oncol 108 2013 174 179
21. S. Habbous, L.T. Harland, A. La Delfa, E. Fadhel, W. Xu, and F.F. Liu Comorbidity and prognosis in head and neck cancers: differences by subsite, stage, and human papillomavirus status Head Neck 36 2014 802 810
22. A.A. Ankola, R.V. Smith, R.D. Burk, M.B. Prystowsky, C. Sarta, and N.F. Schlecht Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population Oral Oncol 49 2013 911 917
23. A.G. Egelmeer, E.R. Velazquez, J.M. de Jong, C. Oberije, Y. Geussens, and S. Nuyts Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients Radiother Oncol 100 2011 108 115
24. P. Lambin, E. Rios-Velazquez, R. Leijenaar, S. Carvalho, R.G. van Stiphout, and P. Granton Radiomics: extracting more information from medical images using advanced feature analysis Eur J Cancer 48 2012 441 446
25. P. Lassen, J. Overgaard, and J.G. Eriksen Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials Radiother Oncol 108 2013 489 494
26. N. Reimers, H.U. Kasper, S.J. Weissenborn, H. Stutzer, S.F. Preuss, and T.K. Hoffmann Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
27. P. Bossi, E. Orlandi, R. Miceli, F. Perrone, M. Guzzo, and L. Mariani Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis Ann Oncol 25 2014 694 699